Business & Economy
Pfizer’s Legal Battle Exposes Risky Globalist Tactics in Pharma Takeovers
By Patriot News Investigative Desk
|
November 1, 2025
Pfizer takes a stand against Novo Nordisk’s aggressive $9 billion bid for Metsera, highlighting the risks of market dominance and regulatory uncertainty that threaten fair competition and American innovation.
This is Exclusive Content for Subscribers
Join our community of patriots to read the full story and get access to all our exclusive analysis.
View Subscription Plans